MGP Ingredients reports Q2 2026 sales of $124.4 million and adjusted EBITDA of $27.6 million amid margin guidance.
MGP Ingredients maintained its 2026 adjusted EBITDA outlook of $90M-$98M during its Q2 2026 earnings call. The company reported second-quarter sales of $124.4 million, a decline from the prior year, alongside adjusted EBITDA of $27.6 million and adjusted EPS of $0.72.
Management attributed the year-over-year drop to expected market conditions but reiterated confidence in high single to low double-digit margins for its Ingredient Solutions segment. The guidance aligns with earlier projections, reflecting stability in long-term performance expectations.
No immediate market reaction was detailed in the call summary.